Phenomenological model of transthyretin stabilization

Area of Science:

• Biochemistry
• Pharmacology
• Computational Biology

Background:

• Transthyretin (TTR) amyloidosis is caused by misfolded TTR monomers forming amyloid fibrils.
• Kinetic stabilizers (e.g., tafamidis) aim to prevent TTR tetramer dissociation, a key step in disease pathogenesis.
• Clinical observations show increased TTR levels post-stabilizer treatment, a phenomenon requiring explanation.

Purpose of the Study:

• To investigate the mechanisms behind the observed increase in TTR levels during kinetic stabilizer treatment.
• To determine if reduced TTR tetramer dissociation alone explains the elevated TTR levels.
• To explore alternative mechanisms influencing TTR homeostasis, such as altered clearance, synthesis, or monomer removal.

Main Methods:

• Development and application of a simple phenomenological model.
• Integration of pharmacokinetic and pharmacodynamic data.
• Analysis of experimental observations.

Main Results:

• The study explores whether reduced TTR dissociation adequately explains increased TTR levels.
• Alternative mechanisms, including altered cellular internalization, degradation, synthesis (pharmacological chaperoning), and monomer re-association, are investigated.
• The model provides insights into TTR homeostasis.

Conclusions:

• Reduced dissociation alone may not fully account for increased TTR levels with stabilizers.
• Stabilizers might influence TTR clearance and synthesis pathways.
• The study highlights the utility of simplified models in identifying key questions for TTR research.